{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T18:14:29Z","timestamp":1776276869759,"version":"3.50.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T00:00:00Z","timestamp":1700784000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T00:00:00Z","timestamp":1700784000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100018552","name":"Taizhou Science and Technology Project","doi-asserted-by":"crossref","award":["20ywb135"],"award-info":[{"award-number":["20ywb135"]}],"id":[{"id":"10.13039\/501100018552","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100018552","name":"Science and Technology Plan Project of Taizhou","doi-asserted-by":"publisher","award":["21ywb123"],"award-info":[{"award-number":["21ywb123"]}],"id":[{"id":"10.13039\/501100018552","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Wenling Science and Technology Project","award":["2021S00158"],"award-info":[{"award-number":["2021S00158"]}]},{"name":"Wenling Science and Technology Project","award":["2021S00148"],"award-info":[{"award-number":["2021S00148"]}]},{"name":"The Medical Health Science and Technology Project of Zhejiang Provincial Health Commission","award":["2021KY1228"],"award-info":[{"award-number":["2021KY1228"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Neuroblastoma, a neuroendocrine tumor originating from the sympathetic ganglia, is one of the most common malignancies in childhood. <jats:italic>RTEL1<\/jats:italic> is critical in many fundamental cellular processes, such as DNA replication, DNA damage repair, genomic integrity, and telomere stability. Single nucleotide polymorphisms (SNPs) in the <jats:italic>RTEL1<\/jats:italic> gene have been reported to confer susceptibility to multiple cancers, but their contributing roles in neuroblastoma remain unclear.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We conducted a study on 402 neuroblastoma cases and 473 controls to assess the association between four <jats:italic>RTEL1<\/jats:italic> SNPs (rs3761124 T&gt;C, rs3848672 T&gt;C, rs3208008 A&gt;C and rs2297441 G&gt;A) and neuroblastoma susceptibility.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Our results show that rs3848672 T&gt;C is significantly associated with an increased risk of neuroblastoma [CC vs. TT\/TC: adjusted odds ratio (OR)=1.39, 95% confidence interval (CI)=1.02-1.90, <jats:italic>P<\/jats:italic>=0.038]. The stratified analysis further indicated that boy carriers of the rs3848672 CC genotype had a higher risk of neuroblastoma, and all carriers had an increased risk of developing neuroblastoma of mediastinum origin. Moreover, the rs2297441 AA genotype increased neuroblastoma risk in girls and predisposed children to neuroblastoma arising from retroperitoneal.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Our study indicated that the rs3848672 CC and rs2297441 AA genotypes of the <jats:italic>RTEL1<\/jats:italic> gene are significantly associated with an increased risk of neuroblastoma in Chinese children in a gender- and site-specific manner.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12885-023-11642-3","type":"journal-article","created":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T22:01:18Z","timestamp":1700863278000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["RTEL1 gene polymorphisms and neuroblastoma risk in Chinese children"],"prefix":"10.1186","volume":"23","author":[{"given":"Ting","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunlei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiejie","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiamin","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiyan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,11,24]]},"reference":[{"key":"11642_CR1","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.bbrc.2021.06.053","volume":"567","author":"E Ivanova","year":"2021","unstructured":"Ivanova E, Sharma SD, Brichkina A, Pfefferle P, Keber U, Pagenstecher A, et al. DYRK3 contributes to differentiation and hypoxic control in neuroblastoma. Biochem Biophys Res Commun. 2021;567:215\u201321.","journal-title":"Biochem Biophys Res Commun."},{"key":"11642_CR2","first-page":"288","volume":"51","author":"PP Bao","year":"2013","unstructured":"Bao PP, Li K, Wu CX, Huang ZZ, Wang CF, Xiang YM, et al. Recent incidences and trends of childhood malignant solid tumors in Shanghai, 2002-2010. Zhonghua Er Ke Za Zhi. 2013;51:288\u201394.","journal-title":"Zhonghua Er Ke Za Zhi."},{"key":"11642_CR3","first-page":"5","volume":"6","author":"HJ Meany","year":"2019","unstructured":"Meany HJ. Non-High-Risk Neuroblastoma: Classification and Achievements in Therapy. Children (Basel). 2019;6:5.","journal-title":"Children (Basel)."},{"key":"11642_CR4","doi-asserted-by":"publisher","first-page":"e27556","DOI":"10.1002\/pbc.27556","volume":"66","author":"DA Morgenstern","year":"2019","unstructured":"Morgenstern DA, Bagatell R, Cohn SL, Hogarty MD, Maris JM, Moreno L, et al. The challenge of defining \u201cultra-high-risk\u201d neuroblastoma. Pediatr Blood Cancer. 2019;66:e27556.","journal-title":"Pediatr Blood Cancer."},{"key":"11642_CR5","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1093\/jjco\/hyx176","volume":"48","author":"A Nakagawara","year":"2018","unstructured":"Nakagawara A, Li Y, Izumi H, Muramori K, Inada H, Nishi M. Neuroblastoma. Jpn J Clin Oncol. 2018;48:214\u201341.","journal-title":"Jpn J Clin Oncol."},{"key":"11642_CR6","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1200\/JCO.2008.16.6785","volume":"27","author":"SL Cohn","year":"2009","unstructured":"Cohn SL, Pearson AD, London WB, Monclair T, Ambros PF, Brodeur GM, et al. The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report. J Clin Oncol. 2009;27:289\u201397.","journal-title":"J Clin Oncol."},{"key":"11642_CR7","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3390\/jpm11050395","volume":"11","author":"JZR Han","year":"2021","unstructured":"Han JZR, Hastings JF, Phimmachanh M, Fey D, Kolch W, Croucher DR. Personalized Medicine for Neuroblastoma: Moving from Static Genotypes to Dynamic Simulations of Drug Response. J Pers Med. 2021;11:395.","journal-title":"J Pers Med."},{"key":"11642_CR8","doi-asserted-by":"publisher","first-page":"16078","DOI":"10.1038\/nrdp.2016.78","volume":"2","author":"KK Matthay","year":"2016","unstructured":"Matthay KK, Maris JM, Schleiermacher G, Nakagawara A, Mackall CL, Diller L, et al. Neuroblastoma. Nat Rev Dis Primers. 2016;2:16078.","journal-title":"Nat Rev Dis Primers."},{"key":"11642_CR9","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/s41571-022-00643-z","volume":"19","author":"B Qiu","year":"2022","unstructured":"Qiu B, Matthay KK. Advancing therapy for neuroblastoma. Nat Rev Clin Oncol. 2022;19:515\u201333.","journal-title":"Nat Rev Clin Oncol."},{"key":"11642_CR10","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S1470-2045(13)70548-5","volume":"15","author":"G Gatta","year":"2014","unstructured":"Gatta G, Botta L, Rossi S, Aareleid T, Bielska-Lasota M, Clavel J, et al. Childhood cancer survival in Europe 1999\u20132007: results of EUROCARE-5\u2013a population-based study. Lancet Oncol. 2014;15:35\u201347.","journal-title":"Lancet Oncol."},{"key":"11642_CR11","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3322\/caac.21219","volume":"64","author":"E Ward","year":"2014","unstructured":"Ward E, DeSantis C, Robbins A, Kohler B, Jemal A. Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin. 2014;64:83\u2013103.","journal-title":"CA Cancer J Clin."},{"key":"11642_CR12","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.canlet.2015.04.021","volume":"363","author":"R Zheng","year":"2015","unstructured":"Zheng R, Peng X, Zeng H, Zhang S, Chen T, Wang H, et al. Incidence, mortality and survival of childhood cancer in China during 2000\u20132010 period: A population-based study. Cancer Lett. 2015;363:176\u201380.","journal-title":"Cancer Lett."},{"key":"11642_CR13","doi-asserted-by":"publisher","first-page":"102355","DOI":"10.1016\/j.ctrv.2022.102355","volume":"104","author":"ASR Westerveld","year":"2022","unstructured":"Westerveld ASR, van Dalen EC, Asogwa OA, Koopman MMW, Papadakis V, Laureys G, et al. Neuroblastoma survivors at risk for developing subsequent neoplasms: A systematic review. Cancer Treat Rev. 2022;104:102355.","journal-title":"Cancer Treat Rev."},{"key":"11642_CR14","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1038\/nature07261","volume":"455","author":"YP Mosse","year":"2008","unstructured":"Mosse YP, Laudenslager M, Longo L, Cole KA, Wood A, Attiyeh EF, et al. Identification of ALK as a major familial neuroblastoma predisposition gene. Nature. 2008;455:930\u20135.","journal-title":"Nature."},{"key":"11642_CR15","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1093\/aje\/kwh108","volume":"159","author":"MN Cook","year":"2004","unstructured":"Cook MN, Olshan AF, Guess HA, Savitz DA, Poole C, Blatt J, et al. Maternal medication use and neuroblastoma in offspring. Am J Epidemiol. 2004;159:721\u201331.","journal-title":"Am J Epidemiol."},{"key":"11642_CR16","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1126\/science.6719137","volume":"224","author":"Consortium IHGS","year":"1984","unstructured":"Consortium IHGS. Finishing the euchromatic sequence of the human genome. Science. 1984;224:1121\u20134.","journal-title":"Science."},{"key":"11642_CR17","doi-asserted-by":"publisher","first-page":"73","DOI":"10.2174\/1573396314666180129101627","volume":"14","author":"N Aygun","year":"2018","unstructured":"Aygun N. Biological and Genetic Features of Neuroblastoma and Their Clinical Importance. Curr Pediatr Rev. 2018;14:73\u201390.","journal-title":"Curr Pediatr Rev."},{"key":"11642_CR18","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1126\/science.6719137","volume":"224","author":"GM Brodeur","year":"1984","unstructured":"Brodeur GM, Seeger RC, Schwab M, et al. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science. 1984;224:1121\u20134.","journal-title":"Science."},{"key":"11642_CR19","doi-asserted-by":"publisher","first-page":"9280","DOI":"10.1038\/sj.onc.1208157","volume":"23","author":"V van Limpt","year":"2004","unstructured":"van Limpt V, Schramm A, van Lakeman A, Sluis P, Chan A, van Noesel M, et al. The Phox2B homeobox gene is mutated in sporadic neuroblastomas. Oncogene. 2004;23:9280\u20138.","journal-title":"Oncogene."},{"key":"11642_CR20","doi-asserted-by":"publisher","first-page":"dju047","DOI":"10.1093\/jnci\/dju047","volume":"106","author":"SJ Diskin","year":"2014","unstructured":"Diskin SJ, Capasso M, Diamond M, Oldridge DA, Conkrite K, Bosse KR, et al. Rare variants in TP53 and susceptibility to neuroblastoma. J Natl Cancer Inst. 2014;106:dju047.","journal-title":"J Natl Cancer Inst."},{"key":"11642_CR21","doi-asserted-by":"publisher","first-page":"3155","DOI":"10.1158\/0008-5472.CAN-14-3613","volume":"75","author":"MR Russell","year":"2015","unstructured":"Russell MR, Penikis A, Oldridge DA, Alvarez-Dominguez JR, McDaniel L, Diamond M, et al. CASC15-S Is a Tumor Suppressor lncRNA at the 6p22 Neuroblastoma Susceptibility Locus. Cancer Res. 2015;75:3155\u201366.","journal-title":"Cancer Res."},{"key":"11642_CR22","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.tranon.2017.09.008","volume":"10","author":"J He","year":"2017","unstructured":"He J, Zou Y, Wang T, Zhang R, Yang T, Zhu J, et al. Genetic Variations of GWAS-Identified Genes and Neuroblastoma Susceptibility: a Replication Study in Southern Chinese Children. Transl Oncol. 2017;10:936\u201341.","journal-title":"Transl Oncol."},{"key":"11642_CR23","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1038\/ng.2436","volume":"44","author":"JJ Molenaar","year":"2012","unstructured":"Molenaar JJ, Domingo-Fernandez R, Ebus ME, Lindner S, Koster J, Drabek K, et al. LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression. Nat Genet. 2012;44:1199\u2013206.","journal-title":"Nat Genet."},{"key":"11642_CR24","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/nature14980","volume":"526","author":"M Peifer","year":"2015","unstructured":"Peifer M, Hertwig F, Roels F, Dreidax D, Gartlgruber M, Menon R, et al. Telomerase activation by genomic rearrangements in high-risk neuroblastoma. Nature. 2015;526:700\u20134.","journal-title":"Nature."},{"key":"11642_CR25","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1001\/jama.2012.228","volume":"307","author":"NK Cheung","year":"2012","unstructured":"Cheung NK, Zhang J, Lu C, Parker M, Bahrami A, Tickoo SK, et al. Association of age at diagnosis and genetic mutations in patients with neuroblastoma. JAMA. 2012;307:1062\u201371.","journal-title":"JAMA."},{"key":"11642_CR26","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/nature09609","volume":"469","author":"K Wang","year":"2011","unstructured":"Wang K, Diskin SJ, Zhang H, Attiyeh EF, Winter C, Hou C, et al. Integrative genomics identifies LMO1 as a neuroblastoma oncogene. Nature. 2011;469:216\u201320.","journal-title":"Nature."},{"key":"11642_CR27","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1038\/nature08035","volume":"459","author":"SJ Diskin","year":"2009","unstructured":"Diskin SJ, Hou C, Glessner JT, Attiyeh EF, Laudenslager M, Bosse K, et al. Copy number variation at 1q21.1 associated with neuroblastoma. Nature. 2009;459:987\u201391.","journal-title":"Nature."},{"key":"11642_CR28","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1038\/ng.374","volume":"41","author":"M Capasso","year":"2009","unstructured":"Capasso M, Devoto M, Hou C, Asgharzadeh S, Glessner JT, Attiyeh EF, et al. Common variations in BARD1 influence susceptibility to high-risk neuroblastoma. Nat Genet. 2009;41:718\u201323.","journal-title":"Nat Genet."},{"key":"11642_CR29","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1093\/jnci\/djac012","volume":"114","author":"X Chang","year":"2022","unstructured":"Chang X, Liu Y, Glessner J, Hou C, Qu H, Nguyen K, et al. Identification of Mitochondrial DNA Variants Associated With Risk of Neuroblastoma. J Natl Cancer Inst. 2022;114:910\u20133.","journal-title":"J Natl Cancer Inst."},{"key":"11642_CR30","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.cell.2008.08.016","volume":"135","author":"LJ Barber","year":"2008","unstructured":"Barber LJ, Youds JL, Ward JD, McIlwraith MJ, O\u2019Neil NJ, Petalcorin MIR, et al. RTEL1 Maintains Genomic Stability by Suppressing Homologous Recombination. Cell. 2008;135:261\u201371.","journal-title":"Cell."},{"key":"11642_CR31","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.cell.2004.05.026","volume":"117","author":"H Ding","year":"2004","unstructured":"Ding H, Schertzer M, Wu X, Gertsenstein M, Selig S, Kammori M, et al. Regulation of murine telomere length by Rtel: an essential gene encoding a helicase-like protein. Cell. 2004;117:873\u201386.","journal-title":"Cell."},{"key":"11642_CR32","doi-asserted-by":"publisher","first-page":"e0207660","DOI":"10.1371\/journal.pone.0207660","volume":"13","author":"S Namgoong","year":"2018","unstructured":"Namgoong S, Cheong HS, Kim JH, Kim LH, Seo JY, Kang SG, et al. Association analysis of RTEL1 variants with risk of adult gliomas in a Korean population. PLoS One. 2018;13:e0207660.","journal-title":"PLoS One."},{"key":"11642_CR33","doi-asserted-by":"publisher","first-page":"70475","DOI":"10.18632\/oncotarget.12297","volume":"7","author":"S Yan","year":"2016","unstructured":"Yan S, Xia R, Jin T, Ren H, Yang H, Li J, et al. RTEL1 polymorphisms are associated with lung cancer risk in the Chinese Han population. Oncotarget. 2016;7:70475\u201380.","journal-title":"Oncotarget."},{"key":"11642_CR34","first-page":"2294","volume":"5","author":"T Jin","year":"2015","unstructured":"Jin T, Wang Y, Li G, Du S, Yang H, Geng T, et al. Analysis of difference of association between polymorphisms in the XRCC5, RPA3 and RTEL1 genes and glioma, astrocytoma and glioblastoma. Am J Cancer Res. 2015;5:2294\u2013300.","journal-title":"Am J Cancer Res."},{"key":"11642_CR35","doi-asserted-by":"publisher","first-page":"e550","DOI":"10.1002\/mgg3.550","volume":"7","author":"S Lu","year":"2019","unstructured":"Lu S, Zhong J, Wu M, Huang K, Zhou Y, Zhong Z, et al. Genetic analysis of the relation of telomere length-related gene (RTEL1) and coronary heart disease risk. Mol Genet Genomic Med. 2019;7:e550.","journal-title":"Mol Genet Genomic Med."},{"key":"11642_CR36","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1093\/qjmed\/hcab315","volume":"115","author":"ZZ Yuan","year":"2022","unstructured":"Yuan ZZ, Fan LL, Wang CY, Luo H, Liu L. Novel heterozygous mutation of RTEL1 in interstitial pneumonia with autoimmune feature. QJM. 2022;115:253\u20135.","journal-title":"QJM."},{"key":"11642_CR37","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1007\/s10875-020-00829-z","volume":"40","author":"A Ziv","year":"2020","unstructured":"Ziv A, Werner L, Konnikova L, Awad A, Jeske T, Hastreiter M, et al. An RTEL1 Mutation Links to Infantile-Onset Ulcerative Colitis and Severe Immunodeficiency. J Clin Immunol. 2020;40:1010\u20139.","journal-title":"J Clin Immunol."},{"key":"11642_CR38","doi-asserted-by":"publisher","first-page":"147120","DOI":"10.1016\/j.gene.2022.147120","volume":"854","author":"L Lin","year":"2023","unstructured":"Lin L, Deng C, Zhou C, Zhang X, Zhu J, Liu J, et al. NSUN2 gene rs13181449 C>T polymorphism reduces neuroblastoma risk. Gene. 2023;854:147120.","journal-title":"Gene."},{"key":"11642_CR39","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1111\/jcmm.17820","volume":"27","author":"J Chang","year":"2023","unstructured":"Chang J, Lin L, Zhou C, Zhang X, Yang T, Wu H, et al. Functional polymorphisms of the TET1 gene increase the risk of neuroblastoma in Chinese children. J Cell Mol Med. 2023;27:2239\u201348.","journal-title":"J Cell Mol Med."},{"key":"11642_CR40","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.omto.2020.12.013","volume":"20","author":"J He","year":"2021","unstructured":"He J, Yuan L, Lin H, Lin A, Chen H, Luo A, et al. Genetic variants in m(6)A modification core genes are associated with glioma risk in Chinese children. Mol Ther Oncolytics. 2021;20:199\u2013208.","journal-title":"Mol Ther Oncolytics."},{"key":"11642_CR41","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1007\/s12519-022-00562-0","volume":"18","author":"YP Chen","year":"2022","unstructured":"Chen YP, Liao YX, Zhuo ZJ, Yuan L, Lin HR, Miao L, et al. Association between genetic polymorphisms of base excision repair pathway and glioma susceptibility in Chinese children. World J Pediatr. 2022;18:632\u20135.","journal-title":"World J Pediatr."},{"key":"11642_CR42","doi-asserted-by":"publisher","first-page":"140","DOI":"10.21147\/j.issn.1000-9604.2023.02.05","volume":"35","author":"Q Guan","year":"2023","unstructured":"Guan Q, Lin H, Hua W, Lin L, Liu J, Deng L, et al. Variant rs8400 enhances ALKBH5 expression through disrupting miR-186 binding and promotes neuroblastoma progression. Chin J Cancer Res. 2023;35:140\u201362.","journal-title":"Chin J Cancer Res."},{"key":"11642_CR43","doi-asserted-by":"publisher","first-page":"3555","DOI":"10.1093\/bioinformatics\/btv402","volume":"31","author":"MJ Machiela","year":"2015","unstructured":"Machiela MJ, Chanock SJ. LDlink: a web-based application for exploring population-specific haplotype structure and linking correlated alleles of possible functional variants. Bioinformatics. 2015;31:3555\u20137.","journal-title":"Bioinformatics."},{"key":"11642_CR44","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/978-981-13-2835-0_9","volume":"90","author":"SG Telomeres","year":"2018","unstructured":"Telomeres SG. Telomerase and Ageing. Subcell Biochem. 2018;90:221\u2013308.","journal-title":"Subcell Biochem."},{"key":"11642_CR45","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.tcb.2014.01.004","volume":"24","author":"JB Vannier","year":"2014","unstructured":"Vannier JB, Sarek G, Boulton SJ. RTEL1: functions of a disease-associated helicase. Trends Cell Biol. 2014;24:416\u201325.","journal-title":"Trends Cell Biol."},{"key":"11642_CR46","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1126\/science.1183112","volume":"327","author":"J L Youds","year":"2010","unstructured":"Youds J L, Mets D G, McIlwraith M J, Martin J S, Ward J D, Oneil N J, et al. RTEL-1 Enforces Meiotic Crossover Interference and Homeostasis. Science. 2010;327:1254\u20138.","journal-title":"Science"},{"key":"11642_CR47","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.cell.2004.10.011","volume":"119","author":"RC Wang","year":"2004","unstructured":"Wang RC, Smogorzewska A, de Lange T. Homologous recombination generates T-loop-sized deletions at human telomeres. Cell. 2004;119:355\u201368.","journal-title":"Cell."},{"key":"11642_CR48","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1007\/s11248-011-9586-7","volume":"21","author":"X Wu","year":"2012","unstructured":"Wu X, Sandhu S, Nabi Z, Ding H. Generation of a mouse model for studying the role of upregulated RTEL1 activity in tumorigenesis. Transgenic Res. 2012;21:1109\u201315.","journal-title":"Transgenic Res."},{"key":"11642_CR49","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/gcc.2870140302","volume":"14","author":"M Muleris","year":"1995","unstructured":"Muleris M, Almeida A, Gerbault-Seureau M, Malfoy B, Dutrillaux B. Identification of amplified DNA sequences in breast cancer and their organization within homogeneously staining regions. Genes Chromosomes Cancer. 1995;14:155\u201363.","journal-title":"Genes Chromosomes Cancer."},{"key":"11642_CR50","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/ng.407","volume":"41","author":"S Shete","year":"2009","unstructured":"Shete S, Hosking FJ, Robertson LB, Dobbins SE, Sanson M, Malmer B, et al. Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet. 2009;41:899\u2013904.","journal-title":"Nat Genet."},{"key":"11642_CR51","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s11060-010-0506-0","volume":"104","author":"KM Egan","year":"2011","unstructured":"Egan KM, Thompson RC, Nabors LB, Olson JJ, Brat DJ, Larocca RV, et al. Cancer susceptibility variants and the risk of adult glioma in a US case-control study. J Neurooncol. 2011;104:535\u201342.","journal-title":"J Neurooncol."},{"key":"11642_CR52","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s11033-019-05178-8","volume":"47","author":"M Viana-Pereira","year":"2020","unstructured":"Viana-Pereira M, Moreno DA, Linhares P, Amorim J, Nabico R, Costa S, et al. Replication of GWAS identifies RTEL1, CDKN2A\/B, and PHLDB1 SNPs as risk factors in Portuguese gliomas patients. Mol Biol Rep. 2020;47:877\u201386.","journal-title":"Mol Biol Rep."}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-023-11642-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-023-11642-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-023-11642-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T23:02:36Z","timestamp":1700866956000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-023-11642-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,24]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["11642"],"URL":"https:\/\/doi.org\/10.1186\/s12885-023-11642-3","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,24]]},"assertion":[{"value":"1 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research has obtained approval from the institutional review board of the Children\u2019s Hospital of Nanjing Medical University (Approval No: 202112141-1). According to the Declaration of Helsinki, written informed consent was obtained from each participant. All participants\u2019 parents or guardians signed an informed consent form.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1145"}}